SUPN Supernus Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
31.4%
Ruim
11/14 critérios · 5a dados
Dados de Mercado
- P/L (Forward)
- 11.9
- P/L (Trailing)
- —
- P/VP
- 2.72
- Market Cap
- $2.9B
- Enterprise Value
- $2.6B
Último Ano Fiscal
Dec 2025
- Receita
- $719.0M
- EBIT
- -$49.0M
- EBITDA
- $42.5M
- FCO
- $47.3M
- FCF
- $46.0M
Histórico Anual
| Ano | Receita | EBIT | EBITDA | FCO | FCF |
|---|---|---|---|---|---|
| 2021 | — | — | — | — | — |
| 2022 | $667.2M | $67.8M | $153.4M | $116.8M | $116.4M |
| 2023 | $607.5M | $5.2M | $90.0M | $111.1M | $110.5M |
| 2024 | $661.8M | $97.9M | $178.3M | $172.0M | $171.2M |
| 2025 | $719.0M | -$49.0M | $42.5M | $47.3M | $46.0M |
Quer uma análise mais profunda?
Nossos clientes recebem análises completas com valuation, tese de investimento e acompanhamento contínuo.
Falar com Especialista